OverviewZogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$10.25 - 0.38
Data as of 04/29/16 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
Investor Events More
Wednesday, February 10, 2016 10:40 a.m. ET
Zogenix, Inc. at LEERINK Partners 5th Annual Global Healthcare Conference
Wednesday, November 18, 2015 11:00 a.m. ET
Zogenix, Inc. at Stifel 2015 Healthcare Conference